PepGen (PEPG) Cash from Financing Activities (2021 - 2026)
PepGen (PEPG) reported Cash from Financing Activities of $1.5 million for Q1 2026, up 987.72% sequentially from -$171000.0 in Q4 2025.
PepGen (PEPG) Cash from Financing Activities (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Cash from Financing Activities data on file, last reported at $1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Financing Activities changed N/A year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $109.5 million (up 6044.61% YoY), and the FY2025 full-year result was $108.0 million, up 21.67% from the prior year.
- Cash from Financing Activities advanced to $1.5 million in Q1 2026, from -$171000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $113.4 million in Q2 2022 to a low of -$1.4 million in Q3 2022.
- A 5-year average of $19.4 million and a median of $129000.0 in 2023 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities surged 66797.69% in 2024 and slumped 233.59% in 2025, its largest moves.
- Tracing PEPG's Cash from Financing Activities over 5 years: stood at $217000.0 in 2022, then plunged by 88.02% to $26000.0 in 2023, then jumped by 392.31% to $128000.0 in 2024, then tumbled by 233.59% to -$171000.0 in 2025, then soared by 987.72% to $1.5 million in 2026.
- Business Quant data shows PEPG's Cash from Financing Activities at $1.5 million in Q1 2026, -$171000.0 in Q4 2025, and $108.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 30.14 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 68.63 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 9,311.16 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -538.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -802.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 238.74 Mn |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | 1.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.52 Mn |
| Mar 31, 2026 | 1.52 Mn |
| Dec 31, 2025 | -171,000.00 |
| Dec 31, 2025 | -171,000.00 |
| Sep 30, 2025 | 108.05 Mn |
| Sep 30, 2025 | 108.05 Mn |
| Jun 30, 2025 | 98,000.00 |
| Jun 30, 2025 | 98,000.00 |
| Dec 31, 2024 | 128,000.00 |
| Dec 31, 2024 | 128,000.00 |
| Sep 30, 2024 | 327,000.00 |
| Sep 30, 2024 | 327,000.00 |
| Jun 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 86.97 Mn |
| Mar 31, 2024 | 86.97 Mn |
| Dec 31, 2023 | 26,000.00 |
| Dec 31, 2023 | 26,000.00 |
| Sep 30, 2023 | -326,000.00 |
| Sep 30, 2023 | -326,000.00 |